People who’ve survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds. The strategy is “beneficial by reducing major and minor...

Some slow-growing cases of leukemia don’t need constant surveillance by cancer specialists, a new study claims. Low-risk patients with slow-growing chronic lymphocytic leukemia (CLL) and no symptoms fared well even after they stopped seeing doctors for specialized...

Pregnancy transforms women’s bodies in many obvious ways, but new research suggests it may also accelerate aging. Women who had been pregnant appeared to be biologically older than women who had never carried a child, the genetic...

Removal of armpit lymph nodes can leave many breast cancer patients with lingering lymphedema, a painful and unsightly swelling of the arm. Now, new Swedish research may help narrow down which patients require extensive lymph removal, based...

A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows. The vaccine could help liver cancer patients live longer, as...

Spring is in the air, and along with it loads of tree, grass and weed pollen. Sneezing, watery and itchy eyes, runny nose and all the other miseries of seasonal allergies can prevent a person from fully...

A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports. The test looks for eight small RNA particles and eight larger DNA markers shed by pancreatic cancers, which...

Today is your last chance until 2044 to see a total eclipse of the sun in the continental United States. But be sure to protect your eyes if you plan to watch the moon block the sun’s...

Younger generations are aging more rapidly, and this could be leading to an increased risk of cancer, a new study says. People born in or after 1965 are 17% more likely to be experiencing accelerated aging compared...

New research questions the effectiveness of the U.S. Food and Drug Administration’s accelerated drug approval program after finding that many cancer drugs remain unproven five years later. The study, published Sunday in the Journal of the American...